Parotidectomy for Parotid Cancer
- PMID: 26895698
- PMCID: PMC4821693
- DOI: 10.1016/j.otc.2015.10.007
Parotidectomy for Parotid Cancer
Abstract
Parotidectomy for parotid cancer includes management of primary salivary cancer, metastatic cancer to lymph nodes, and direct extension from surrounding structures or cutaneous malignancies. Preoperative evaluation should provide surgeons with enough information to plan a sound operation and adequately counsel patients. Facial nerve sacrifice is sometimes required; but in preoperative functioning nerves, function should be preserved. Although nerve involvement predicts poor outcome, survival of around 50% has been reported for primary parotid malignancy. Metastatic cutaneous squamous cell carcinoma is a high-grade aggressive histology whereby local control for palliation with extended parotidectomy can be achieved; however, overall survival remains poor.
Keywords: Accessory parotid gland carcinoma; Facial nerve; Parotid cancer; Parotidectomy.
Copyright © 2016 Elsevier Inc. All rights reserved.
References
-
- Spiro RH, Huvos AG, Strong EW. Cancer of the parotid gland. A clinicopathologic study of 288 primary cases. Am J Surg. 1975;130(4):452–459. - PubMed
-
- Poorten VV, et al. Prognostic index for patients with parotid carcinoma: international external validation in a Belgian-German database. Cancer. 2009;115(3):540–550. - PubMed
-
- Johns ME. Parotid cancer: a rational basis for treatment. Head Neck Surg. 1980;3(2):132–141. - PubMed
-
- Cohen EG, et al. Fine-needle aspiration biopsy of salivary gland lesions in a selected patient population. Arch Otolaryngol Head Neck Surg. 2004;130(6):773–778. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
